Taken together, the aberrant activation of mTOR is involved in nearly every aspect of AD pathogenesis from the production toward the clearance of proteotoxins and is therefore regarded as a promising therapeutic target (Table 3) (Figure 4). Here, MTOR is linked to Alzheimer disease.